Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$3.71B |
| 2 |
Microsoft
MSFT
|
+$3.52B |
| 3 |
Amazon
AMZN
|
+$2.04B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$1.87B |
| 5 |
Eli Lilly
LLY
|
+$1.31B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.8B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.78B |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$703M |
| 4 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$611M |
| 5 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$573M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.3% |
| 2 | Healthcare | 12.11% |
| 3 | Financials | 10.63% |
| 4 | Consumer Discretionary | 8.09% |
| 5 | Industrials | 6.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5176
Invesco Bloomberg Analyst Rating Improvers ETF
UPGD
$121M
| $400K | ﹤0.01% |
7,378
-345
| -4% | -$18.7K |
|
5177
Banco Bradesco
BBDO
$34.3B
| $400K | ﹤0.01% |
154,868
+7,312
| +5% | +$20.2K |
|
5178
IQ Candriam International Equity ETF
IQSI
$277M
| $398K | ﹤0.01% |
16,067
-1,282
| -7% | -$30.3K |
|
5179
Annovis Bio
ANVS
$80M
| $398K | ﹤0.01% |
29,656
-11,631
| -28% | -$145K |
|
|
TEAD
5180
Teads Holding Co
TEAD
$67.7M
| $398K | ﹤0.01% |
109,886
-51,482
| -32% | -$202K |
|
5181
Parke Bancorp
PKBK
$405M
| $395K | ﹤0.01% |
19,065
+3,010
| +19% | +$63.7K |
|
5182
AN2 Therapeutics
ANTX
$214M
| $394K | ﹤0.01% |
41,305
+1,072
| +3% | +$14.4K |
|
5183
Vident US Equity Strategy ETF
VUSE
$691M
| $393K | ﹤0.01% |
+9,459
| New | +$394K |
|
5184
Cardiff Oncology
CRDF
$77.2M
| $393K | ﹤0.01% |
280,766
-95,970
| -25% | -$137K |
|
|
WBND
5185
DELISTED
Western Asset Total Return ETF
WBND
| $393K | ﹤0.01% |
19,529
-8,397
| -30% | -$166K |
|
5186
Veritone
VERI
$122M
| $392K | ﹤0.01% |
74,018
-57,636
| -44% | -$369K |
|
5187
The ONE Group
STKS
$53M
| $392K | ﹤0.01% |
62,250
-32,290
| -34% | -$211K |
|
5188
Invesco BulletShares 2030 Corporate Bond ETF
BSCU
$2.69B
| $392K | ﹤0.01% |
24,537
+6,937
| +39% | +$110K |
|
5189
iShares US Small Cap Equity Factor ETF
SMLF
$4.3B
| $390K | ﹤0.01% |
7,856
+468
| +6% | +$23.3K |
|
5190
Gilat Satellite Networks
GILT
$848M
| $389K | ﹤0.01% |
67,143
-1,245
| -2% | -$7.05K |
|
5191
Ceragon Networks
CRNT
$201M
| $389K | ﹤0.01% |
203,835
-6,556
| -3% | -$12.3K |
|
5192
VanEck Energy Income ETF
EINC
$77.4M
| $389K | ﹤0.01% |
6,292
-11,115
| -64% | -$690K |
|
5193
Mistras Group
MG
$512M
| $388K | ﹤0.01% |
78,796
-7,097
| -8% | -$32.2K |
|
|
TECX
5194
Tectonic Therapeutic
TECX
$606M
| $387K | ﹤0.01% |
45,286
+2,643
| +6% | +$23.3K |
|
5195
Amerant Bancorp
AMTB
$1.13B
| $386K | ﹤0.01% |
14,371
-18
| -0.1% | -$505 |
|
5196
ARK Israel Innovative Technology ETF
IZRL
$141M
| $382K | ﹤0.01% |
21,794
-200
| -0.9% | -$3.52K |
|
5197
BayCom
BCML
$333M
| $382K | ﹤0.01% |
20,107
+1,991
| +11% | +$37.4K |
|
5198
Torrid Holdings
CURV
$260M
| $380K | ﹤0.01% |
128,489
+73,664
| +134% | +$301K |
|
5199
iShares International Small Cap Equity Factor ETF
ISCF
$681M
| $380K | ﹤0.01% |
12,677
| – | – |
|
5200
Prime Medicine
PRME
$559M
| $379K | ﹤0.01% |
+20,389
| New | +$368K |
|
Similar funds
Morgan Stanley's Q4 2022 Portfolio in Review
As of Q4 2022, Morgan Stanley held 8,205 positions worth $880B, up 20% from $734B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Morgan Stanley deployed $97B of net new capital in Q4 2022, opening 199 new positions and adding to 3,814 existing holdings. Its largest new stake was Rentokil: 2,829,958 shares worth $87.2M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.8B trimmed.
- Morgan Stanley's largest Q4 2022 buy was Rentokil: 2,829,958 shares worth $87.2M.
- Morgan Stanley added most to Apple in Q4 2022, an estimated $3.71B increase.
- Morgan Stanley's biggest Q4 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.8B.
- Morgan Stanley fully exited Twitter, Inc. in Q4 2022, selling an estimated $348M.
- Morgan Stanley's ten largest holdings make up 14% of its $880B portfolio in Q4 2022.
- Morgan Stanley opened 199 new positions and closed 311 in Q4 2022.
- Morgan Stanley's portfolio value rose 20% quarter-over-quarter to $880B.
Based on Morgan Stanley's 13F filing for Q4 2022, filed 14 Feb 2023.